When will you arrange shipment?

Orders are usually dispatched within 3 working days after full payment is confirmed.

PLLA (Poly-L-Lactic Acid) is a biodegradable, biocompatible biostimulator that stimulates the skin's natural collagen production, gradually restoring volume and improving skin texture for long-lasting facial rejuvenation.

What are the main benefits of PLLA?

It boosts collagen synthesis, restores facial volume, smooths fine lines and wrinkles, improves skin laxity, enhances skin texture and firmness, and delivers long-lasting, natural-looking rejuvenation results.

Is PLLA suitable for sensitive skin?

Yes, PLLA is highly biocompatible and well-tolerated by most skin types, including sensitive skin, as it is a fully biodegradable material with minimal risk of allergic reactions.

How soon can I see results?

Immediate mild plumping effect can be seen right after injection; significant collagen regeneration and volume improvement will gradually appear within 4-8 weeks, with optimal results lasting 18-24 months.

Can pregnant or breastfeeding people use PLLA?

For safety reasons, it is strictly not recommended for pregnant or breastfeeding individuals, and consultation with a qualified medical professional is required before any treatment.

Phosphate Buffer One Year Pllafill® Face Mask Plla Dermal Filler

Name: Phosphate Buffer One Year Pllafill® Face Mask Plla Dermal Filler
Brand: SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED
SKU: 2305340365

Shanghai, ChinaSHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

US$20.00-45.00

1 Piece

Sample price:US$45.00/piece.Request sample

Product profile

Customization

Available

Type

Plla Filler

Material

Plastic

Model NO.

1ml

Ethylene Oxide Sterilization

Without Ethylene Oxide Sterilization

Quality Guarantee Period

One Year

Group

Adult

Logo Printing

Without Logo Printing

Product Name

Plla Filler

Keywords

Poly-L-Lactic Acid(Plla) Dermal Filler

OEM & ODM Custom

Logo Custom

Primary Active Ingredient

Poly-L-Lactic Acid Microspheres (Plla) 150mg

Secondary Active Ingredient

Crosslinked Hyaluronic Acid (17mg/Ml)

Anesthetic Component

Lidocaine Hydrochloride (3mg/Ml)

Buffer Solution

Phosphate Buffer

Duration of Effect

18-24 Months

Transport Package

Export Standard Carton Packaging

Specification

Standard Specifications or Customized

Trademark

PLLAFILL®

Origin

Shanghai, China

Production Capacity

1000000pieces/Year

Key features

Dual-Action Formula: Combines PLLA microspheres with crosslinked HA for immediate volume and long-term collagen stimulation.

Extended Duration: Provides visible correction and results lasting 18-24 months through continuous collagen synthesis.

Pain-Free Injection: Formulated with 3mg/mL lidocaine hydrochloride for a comfortable and pain-free treatment experience.

Biodegradable Material: Made from 100% biodegradable materials that metabolize naturally without leaving permanent residues.

OEM & ODM Support: Accepts OEM and ODM customization services for tailored product solutions.

Sample Availability: Provides sample and trial orders to verify product quality and safety before bulk procurement.

Superior Biocompatibility: Minimizes risks of redness, swelling, and foreign body reactions for exceptional safety profiles.

Company profile

Importers and ExportersHigh Repeat Buyers ChoiceYears of Export Experience

SHANGHAI BIOHA BIOLOGICAL TECHNOLOGY COMPANY LIMITED

Shanghai, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableAverage Response Time: ≤15h

AI-Powered supplier vetting

SummarySHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED is a China-based limited company in Shanghai described as both a trading company and manufacturer/factory. Its listed products are filler cannulas, meso needles, and dermal fillers. The supplier reports ISO 13485 certification, more than 10 production lines, 11–20 years of total R&D engineer experience, and sales in more than 30 countries. Export sales account for 90%, and it has self-operated import and export rights. However, the provided information does not establish current audit validity, audit performance, after-sales capability, customization services, customer references, financial credibility, raw-material traceability, or specific R&D/ODM/OEM capabilities. Several operational fields are explicitly marked unknown.

Supplier typeThe supplier is identified as a factory and, more specifically, as both a trading company and manufacturer/factory. It is a China-based limited company operating in Shanghai, indicating manufacturing involvement but also a trading function.

CertificationsThe supplier lists ISO 13485 certification, and a TUV Rheinland audit record is provided with a stated period from August 22, 2024 to August 21, 2025. However, the audit evaluation result is recorded as 0, and the provided information does not clarify the meaning of that result or establish current certification validity.

R&D capabilityThe supplier states that it uses technological breakthroughs, emphasizes technical innovation, conducts market research, listens to customer feedback, and engages in continuous product development. It also reports 11–20 years of total R&D engineer experience, but specific new-product output and SDK-related R&D capability are unknown.

Production capacityThe supplier is identified as a manufacturer/factory, lists more than 10 production lines, and offers filler cannulas, meso needles, and dermal fillers. These facts explicitly support manufacturing capacity, although the audit evaluation result of 0 is not explained in the provided information.

Client casesThe supplier states that its products are sold in more than 30 countries and recognized by customers. However, collaboration with Fortune 500 companies is unknown, and no named customers, customer projects, or verifiable case details are provided.